Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed
Weight Loss & Fat Loss

Tesofensine for Weight Loss: Trial Results, Doses and Side Effects

Tesofensine curbed appetite and produced 9-11% more weight loss than placebo in a 24-week trial. How it works, doses studied, heart-rate effects and why it is still unapproved.

Updated 17 min read
Man measuring his waist with a tape measure in a kitchen beside a plate of vegetables, for an article on tesofensine for weight loss
Contents11 sections

Hunger is the main reason most diets fail. When calories drop, appetite climbs, cravings get louder and energy dips, and sooner or later most people eat their way back. Tesofensine is an experimental drug that works on that problem directly: it changes the brain chemistry that drives appetite.

It was first developed for Parkinson’s and Alzheimer’s disease, but patients in those trials lost weight, and it was then tested as an obesity treatment. In a 24-week trial published in The Lancet, it produced clearly more weight loss than placebo, mostly by making people less hungry.

This guide covers how tesofensine works, what the human trials found (and what comes only from animal studies), the doses used in studies, its effect on heart rate and blood pressure, and why it is still not an approved medicine.

Tesofensine is an investigational drug. It is not approved by the FDA or the European Medicines Agency for weight loss or any other use, and products sold online are labelled for research only. This article is for educational purposes only and is not medical advice or an endorsement of tesofensine use. Always consult a qualified healthcare professional before taking any weight-loss medication. Muscle & Brawn is an independent publication and may receive a commission on purchases made through affiliate links in this article. Read our full disclaimer for details.

Key Takeaways

  • Tesofensine is an experimental oral drug that blocks the reuptake of serotonin, noradrenaline and dopamine. Its main effect is a lower appetite.
  • In the 24-week Lancet trial, people taking 0.5 mg or 1.0 mg daily with a reduced-calorie diet lost roughly 9-11% more body weight than those on placebo.
  • It is taken by mouth once a day, not injected. Studies used 0.25-1.0 mg; the 1.0 mg dose added little weight loss over 0.5 mg but caused more side effects.
  • Blood pressure did not rise at 0.25 mg or 0.5 mg in that trial, but resting heart rate went up by about 7 beats per minute at 0.5 mg. Long-term heart safety is unknown.
  • It is not approved by the FDA or in Europe. What is sold online is labelled for research use, and no regulator checks its purity or dose.

What Is Tesofensine?

Tesofensine (development code NS2330) is an experimental drug first developed by the Danish company NeuroSearch to treat Parkinson’s and Alzheimer’s disease. Those programmes did not continue, but researchers noticed that patients lost weight during the trials, which led to its development as an obesity treatment.

Tesofensine is a triple monoamine reuptake inhibitor. It slows the reabsorption of three brain chemicals, dopamine, noradrenaline (norepinephrine) and serotonin, so more of each stays active. These chemicals help regulate appetite, mood, alertness and energy use. Raising all three makes people feel less hungry and fuller on smaller meals, which makes a calorie deficit easier to keep.

It is a small-molecule drug taken by mouth, not a peptide and not an injection. In trials it was given as a once-daily oral dose, and online it is usually sold as capsules. For the full compound profile, see our tesofensine compound page.

Is Tesofensine Approved?

No. Tesofensine is not approved by the US Food and Drug Administration (FDA) or the European Medicines Agency for weight loss or any other use. Its developer’s partner has run a late-stage programme in Mexico, but in the US and Europe it remains an investigational drug.

What you find online is sold as a research chemical, labelled “not for human consumption”. It is a drug, not a dietary supplement, and no regulator checks the purity or strength of these products. That matters for side effects: a capsule that contains more than its label states raises every risk described below.


How Tesofensine Suppresses Appetite

Most of what is known about how tesofensine works comes from animal studies, so it helps to keep the two kinds of evidence apart.

Animal Data

In diet-induced obese rats, tesofensine reduced food intake and body weight, and the effect depended on noradrenaline and dopamine receptor pathways. A rodent study also found that it quiets GABA-releasing neurons in the lateral hypothalamus, a brain area that drives feeding. When those neurons are less active, animals eat less.

Human Data

In people, the measured effect is on appetite: trial participants reported less hunger and more fullness and ate less. A smaller study of energy metabolism in overweight men found that the weight loss came mainly from eating less; any rise in calories burned was small. Tesofensine is best understood as an appetite suppressant, not a fat burner.

Because it raises noradrenaline and dopamine, it does share some effects with stimulant drugs, most clearly a higher resting heart rate. That is covered in the safety section below.


Tesofensine in Clinical Trials: Results and Data

Tesofensine in Clinical Settings

The key obesity study is a randomised, double-blind, placebo-controlled phase 2 trial published in The Lancet in 2008. It enrolled 203 adults with obesity, who took 0.25 mg, 0.5 mg or 1.0 mg of tesofensine, or a placebo, once daily for 24 weeks. Every group also followed a reduced-calorie diet.

Group (24 weeks, with diet)Weight loss compared with placeboNotes
PlaceboAbout 2% of body weight lostThe reference group
Tesofensine 0.25 mgAbout 4.5 percentage points moreSmallest effect
Tesofensine 0.5 mgAbout 9 percentage points moreNo rise in blood pressure; heart rate up about 7 beats per minute
Tesofensine 1.0 mgAbout 10.5 percentage points moreLittle extra over 0.5 mg; more side effects

Two things stand out. The response was dose-dependent up to 0.5 mg, and the jump from 0.5 mg to 1.0 mg added little weight loss but more side effects. The trial also measured waist size and body composition, which improved along with body weight.

The authors described the weight loss at 0.5 mg and 1.0 mg as roughly twice what the obesity drugs approved at the time, such as sibutramine and orlistat, achieved. That is a comparison across separate trials, not a head-to-head study, and newer GLP-1 drugs have changed the picture since then.

The limits matter too. The trial ran for six months with about 200 people. It shows what happens to most people over months, not what happens to rare individuals or over years.


Doses Used in Studies, Timing and Combinations

Optimising Tesofensine

Tesofensine has no approved dose because it is not an approved medicine. The figures below are the doses used in research and the doses people commonly report, not a recommendation.

ItemDetails
RouteOral, once daily (tablet or capsule); not injected
Doses tested in the Lancet trial0.25 mg, 0.5 mg and 1.0 mg once daily
Trial length24 weeks
1.0 mg doseLittle extra weight loss over 0.5 mg, more side effects
Commonly reported doses0.25-0.5 mg once daily
8-12 week “cycles” with breaksAn online convention; not tested in trials
Long-term useNot studied; long-term safety unknown

Timing and the Long Half-Life

Tesofensine has a very long half-life, roughly a week or more in pharmacokinetic studies. Levels build up slowly over weeks of daily dosing and fall slowly after the last dose. That means the full effect of any dose takes weeks to show, side effects can appear late, and they can linger after stopping. It also means the time of day matters less than with short-acting stimulants, although people who sleep poorly on it often take it in the morning.

What Not to Combine It With

Tesofensine already raises heart rate. Adding other drugs that act on the same brain chemicals adds to that strain and raises the risk of interactions. Avoid combining it with:

  • Stimulants and fat burners, including yohimbine, clenbuterol, high-dose caffeine and pre-workouts
  • ADHD medicines and other stimulant drugs
  • Antidepressants (SSRIs, SNRIs, MAO inhibitors), tramadol and other drugs that act on serotonin
  • Other weight-loss drugs

Tesofensine Side Effects and Safety

Possible Tesofensine Side Effects

In the 24-week obesity trial, the most common adverse events caused by tesofensine were dry mouth, nausea, constipation, hard stools, diarrhoea and insomnia, and they were generally more common at higher doses. Resting heart rate also rose. The table sums up what the evidence shows and when a symptom needs medical attention.

Side EffectWhat the Evidence ShowsWhen to Get Help
Dry mouthOne of the most common trial effectsMouth sores, dental pain or trouble swallowing
Nausea and diarrhoeaCommon, more so at higher dosesPersistent vomiting or diarrhoea, signs of dehydration
Constipation and hard stoolsCommon in the trialNo bowel movement for several days, abdominal pain
InsomniaCommon in the trialOngoing sleep loss that affects mood or daily function
Faster heart rateRose by about 7 beats per minute at 0.5 mgPalpitations, chest pain or a resting pulse that stays high
Blood pressureNo rise at 0.25 mg or 0.5 mg over 24 weeksAny sustained rise on home readings
Mood changesPossible from the mechanism; not well quantified in published trialsAnxiety, agitation, low mood or unusual thoughts

Dry Mouth and Digestive Effects

Gastrointestinal effects are the most frequent complaints. Dry mouth comes from reduced saliva flow, a known effect of drugs that raise noradrenaline. Nausea, constipation, hard stools and diarrhoea also appeared in the trial, partly because serotonin acts on the gut as well as the brain.

Because tesofensine builds up slowly, these effects can start a few weeks in rather than on day one. Water, fibre and regular meals help with constipation, and sugar-free gum or lozenges help with dry mouth. Persistent vomiting, diarrhoea or abdominal pain need medical attention.

Insomnia and Restlessness

Insomnia was one of the common trial effects. Higher dopamine and noradrenaline increase alertness, which can make it harder to fall asleep or stay asleep. Restlessness, jitteriness and headaches are also commonly reported by users, especially when tesofensine is combined with caffeine or other stimulants.

Because of the long half-life, taking the dose earlier in the day helps less than it does with short-acting stimulants. Cutting back on caffeine, keeping a regular sleep schedule and not raising the dose are the practical levers.

Heart Rate and Blood Pressure

This is the side effect that matters most. Noradrenaline raises heart rate, and in the 24-week trial the 0.5 mg dose increased resting heart rate by about 7 beats per minute. Blood pressure did not rise at 0.25 mg or 0.5 mg in that trial.

That is reassuring in the short term, but it is not proof of long-term heart safety: no trial has measured heart attacks or strokes on tesofensine over years. The developer later paired tesofensine with metoprolol, a beta-blocker, in a combination called Tesomet, to blunt the rise in heart rate and blood pressure in patients with hypothalamic obesity.

The cautionary example is sibutramine, a serotonin-noradrenaline reuptake inhibitor for weight loss that was withdrawn from the US and European markets in 2010 after a large trial found more non-fatal heart attacks and strokes in people with existing cardiovascular disease. Anyone with heart disease, an arrhythmia or high blood pressure has the most to lose, and checking resting pulse and blood pressure before starting and regularly afterwards is the simplest safeguard.

Mood and Anxiety

Drugs that change serotonin, dopamine and noradrenaline levels can also change mood. Anxiety, irritability, agitation or low mood are possible, and the published obesity trials do not give a clear picture of how often they happen with tesofensine.

People with a history of depression, bipolar disorder, anxiety disorders or psychosis have very little safety data behind them and should not use tesofensine outside specialist care. New low mood, panic or unusual thoughts are a reason to stop and seek help.

Eating Too Little

Strong appetite suppression is the point of the drug, and tesofensine can produce large weight losses. The risk is eating too little protein and too few nutrients. Rapid weight loss on a very low intake costs muscle as well as fat and can cause fatigue, dizziness and gallstones.

Planning meals around protein and checking weight weekly keeps the loss at a pace the body can handle.


What About Seizures, Serotonin Syndrome and Stroke?

Lists of tesofensine side effects online often include seizures, serotonin syndrome and stroke. None of these is among the effects the published trials reported. They are theoretical risks, based on what related drugs can do:

  • Serotonin syndrome: a dangerous excess of serotonin, mainly a risk when serotonergic drugs are combined. With tesofensine, the realistic risk comes from stacking it with antidepressants (SSRIs, SNRIs, MAO inhibitors), tramadol or other serotonergic substances.
  • Seizures: some reuptake inhibitors, such as bupropion, lower the seizure threshold. Whether tesofensine does has not been shown, and there is no safety data in people with epilepsy.
  • Heart attack and stroke: no trial has shown these with tesofensine. The concern is long-term exposure to a higher heart rate, and the sibutramine precedent.

The honest summary: these events were not seen in trials of a few hundred people over months, which is far too small and too short to rule out rare or long-term harm.

Who Should Avoid It

  • People with heart disease, an arrhythmia, high blood pressure or a previous stroke
  • People with a history of depression, bipolar disorder, anxiety disorders, psychosis or eating disorders
  • Anyone taking the drugs listed in the combinations section above
  • Anyone who is pregnant, breastfeeding or under 18

Compared with approved options, the gap is large. GLP-1 drugs such as semaglutide are approved, made to pharmaceutical standards and backed by years of safety data. Our guide to the best peptides for weight loss covers those alternatives.


How to Reduce the Risk

How To Avoid Tesofensine Side Effects
  1. Involve a doctor: A doctor can check your heart, blood pressure and current medicines first, and spot problems early. This is the single most useful step.
  2. Do not chase higher doses: In the main trial, 1.0 mg added little weight loss over 0.5 mg but brought more side effects. Commonly reported doses sit at the lower end of the studied range.
  3. Monitor heart rate and blood pressure: Check resting pulse and blood pressure before starting and at least weekly while using it. A sustained rise is a reason to stop.
  4. Avoid drug interactions: Do not combine tesofensine with SSRIs, SNRIs, MAO inhibitors, tramadol, ADHD stimulants or other weight-loss drugs.
  5. Limit stimulants: Caffeine, energy drinks, pre-workouts and fat burners add to the rise in heart rate and blood pressure and make insomnia worse.
  6. Eat enough and stay hydrated: Plan meals around protein, vegetables and fluids so that lower appetite does not turn into poor nutrition, constipation or a dry mouth.
  7. Allow for the long half-life: The effect of any dose change takes weeks to show, and side effects can continue for days after the last dose.

Benefits vs. Risks

Benefits of Using Tesofensine

The benefit with solid evidence is weight loss driven by lower appetite. In the trials, tesofensine made a reduced-calorie diet easier to stick to and produced clearly more weight loss than placebo.

Other claims are weaker. Tesofensine was tested in Parkinson’s disease (including a randomised trial) and in Alzheimer’s disease, but neither programme continued, so claims about better focus or memory have no clinical support. Reports of more energy and better mood come from users, not from trials.

Compared with approved options, the trade-off is clear. GLP-1 drugs such as semaglutide are approved, made to pharmaceutical standards and backed by years of safety data, including cardiovascular outcome trials. Tesofensine has none of that. Our guide to peptides for weight loss covers the alternatives in more detail.

Where Tesofensine Is Sold

Tesofensine is not approved by the FDA or the European Medicines Agency, so it is not available on prescription in the US or Europe. It is sold by research-chemical vendors, labelled for research use only, and the rules on buying it differ by country. Check your local regulations first.

SwissChems and NextChems both list it. A certificate of analysis from independent testing gives some assurance about what a batch contains, but it does not make the product safe to take, and everything above about side effects still applies. Speak with a healthcare professional before using any weight-loss drug.

SwissChems
SwissChems Contents6 sections01What Is SwissChems?02Product Range03Top 3 Featured Products04Why It Gets Attention From Fitness Researchers05Testing, Documentation & Regulatory History06Frequently Asked Questions SwissChems is an online research-compound supplier covering SARMs,…
9.2Excellent
Visit SwissChemsBRAWN1010% OFF
Pros
  • Exceptional purity & testing (≥98%)
  • Pharmaceutical-style packaging for stability
  • Broad catalog across peptides & nootropics
  • Strong reputation & consistency across years
Cons
  • Some items frequently out of stock due to high demand
  • Limited long-term data for some compounds
NextChems
NextChems Contents7 sections01What Is NextChems?02Product Range03Top 3 Featured Products04Testing & Quality Documentation05Why It Appeals to the Fitness Community06Regulatory & Safety Considerations07Frequently Asked Questions NextChems is an online supplier of…
8.8Great
Visit NextChemsBRNC1015% OFF
Pros
  • Publishes analytical reports using methods including LC-MS/MS, HPLC-UV/MS, and GC-MS.
  • Shipping coverage includes the US, Canada, Europe, South Asia, the Middle East, and other regions.
  • Relatively competitive pricing.
Cons
  • Customer-reported concerns regarding lost or delayed international shipments.
  • Smaller research catalog than other brands on the market

The Bottom Line

Tesofensine produced real, dose-dependent weight loss in trials by curbing appetite, but it is an unapproved oral drug that raises heart rate and has no long-term safety data.

  • In the 24-week Lancet trial, 0.5 mg and 1.0 mg daily with a reduced-calorie diet produced roughly 9-11% more weight loss than placebo; 1.0 mg added little over 0.5 mg but brought more side effects.
  • It works mainly by lowering appetite through serotonin, noradrenaline and dopamine. It is taken by mouth, not injected, and its long half-life means effects build and fade over weeks.
  • Blood pressure held steady at the lower doses over 24 weeks, but heart rate rose, long-term safety is unknown, and approved drugs such as GLP-1s have far more safety data behind them.

Frequently Asked Questions

In trials of up to 24 weeks, most side effects were mild to moderate: dry mouth, nausea, constipation, diarrhoea and insomnia, more often at higher doses. Blood pressure did not rise at 0.25 mg or 0.5 mg, but heart rate went up. It is not an approved medicine, its long-term safety has not been studied, and products sold online are not regulated, so it should only be considered under medical supervision.
The main obesity trial tested 0.25 mg, 0.5 mg and 1.0 mg once daily for 24 weeks. The 1.0 mg dose added little weight loss over 0.5 mg but caused more side effects. Commonly reported doses are 0.25-0.5 mg once daily. There is no approved dose, and this is not dosing advice.
Tesofensine is taken by mouth. It was given as a once-daily oral dose in clinical trials and is usually sold as capsules. It is a small-molecule drug, not a peptide, and it is not injected.
Stacking is not recommended. Tesofensine already raises heart rate, and combining it with stimulants or fat burners such as yohimbine, clenbuterol or high-dose caffeine adds to that strain. It should also not be combined with antidepressants, MAO inhibitors, tramadol, ADHD medicines or other weight-loss drugs because of the risk of interactions.
It is not available on prescription in the US or Europe. Research-chemical vendors such as SwissChems and NextChems sell it labelled for research use. Independent lab testing helps confirm what a batch contains, but it does not make the product safe or legal everywhere, so check your local rules and speak with a doctor first.
Lower appetite is often noticed within the first weeks. Because tesofensine has a very long half-life, levels build up over several weeks, and in the Lancet trial weight loss continued across the full 24 weeks alongside a reduced-calorie diet.
No. Tesofensine is not approved by the FDA or the European Medicines Agency for weight loss or any other use. It remains an investigational drug, and products sold online are labelled for research only.
In the main 24-week obesity trial, the most common side effects were dry mouth, nausea, constipation, hard stools, diarrhoea and insomnia. Resting heart rate also rose. Side effects were generally more common at higher doses.
The main serious concern is the heart: tesofensine raises resting heart rate, which matters most for people with heart disease or high blood pressure. Serotonin syndrome is a risk mainly when it is combined with antidepressants or other serotonergic drugs. Seizures and stroke have not been shown in trials, but the trials were too small and short to rule them out.
Tesofensine has a very long half-life, so levels build up over weeks and fall slowly after stopping. Side effects can therefore continue for days or longer after the last dose.

Disclaimer

Please read carefully

The information on this site is for educational and informational purposes only, and is not medical advice. Always consult a qualified healthcare professional before using any supplement or medication, or making changes to your health, fitness, or nutrition routine.

Not medical advice

Content here is not a substitute for professional medical advice.

Consult your doctor

Talk to your doctor before starting any supplement or new routine.

Use at your own risk

We are not responsible for adverse effects from acting on this.

Do your research

Make informed decisions about your own health.

No guarantees

Individual results vary. No claims about outcomes.

Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.

Written & researched by

Muscle and Brawn Team

The Morning Dose · Free weekly

The research that matters, in five minutes a week.

Join 300,000+ monthly readers getting the sharpest peptide, TRT, and SARMs research and news broken down without the hype. One email. No filler.

No spam. Unsubscribe anytime. 5-minute read, every week.
Latest issue #2

The Morning Dose #2: The “Wolverine Peptide” Fact-Checked, The Rock’s Real Routine, and What TRT Really Costs

BPC-157: what the research actually shows
The Rock: his real routine and diet, by era
Online TRT cost: the full bill and what comes first
Read time · 1 min Read this issue →

Our Trusted Brands

Our growing community of brands that value quality and innovation.